Rite Aid Opens Two New COVID-19 On-Site Testing Locations in Tri-State Area
16 April 2020 - 5:00PM
Business Wire
Self-Swab Drive-Through Tests Now Available in
Waldwick and Valley Cottage
Rite Aid (NYSE: RAD) continues to expand COVID-19 testing sites
with new locations opening Saturday, in Waldwick, NJ and Valley
Cottage, NY, through its partnership with the U.S. Department of
Health and Human Services (HHS).
In addition to the current self-testing sites in Pennsylvania,
Rite Aid has opened two new locations in the tri-state area, at
Rite Aid stores located at 60 Franklin Turnpike in Waldwick, and
133 Route 303 in Valley Cottage. The sites will be open for testing
9 a.m.-5 p.m. seven days a week and expect to be able to conduct
approximately 200 tests each day through on-line appointments.
In coordination with HHS, the company expects to have additional
drive-up COVID-19 testing locations opening soon at Rite Aid stores
in New York, New Jersey, Ohio, Michigan, and Virginia.
All Rite Aid drive-up COVID-19 testing locations will utilize
self-swab nasal tests overseen by Rite Aid pharmacists. Testing
eligibility is based on guidelines established by the Centers for
Disease Control and Prevention (CDC), which can be found here.
The testing will take place in each store’s parking lot. As part
of the testing process, people must remain in their vehicles from
the time they arrive and until they depart.
Testing will be available at no cost to eligible individuals who
meet criteria established by the CDC. Patients are required to
provide government issued identification, be at least 18 years old
and need to pre-register online at www.riteaid.com in order to
schedule a time slot for testing.
Rite-Aid has partnered with Verily, and will use its Baseline
COVID-19 Program to provide screening, scheduling, and return of
results to participants for Rite-Aid testing sites.
Rite Aid also selected BioReference Laboratories to provide
COVID-19 laboratory testing to all drive-up locations with the goal
of flattening the curve through accessible diagnostic testing.
Clinical oversight for the COVID-19 testing program is provided by
PWNHealth, a national clinician network that enables safe and easy
access to diagnostic testing.
Rite Aid will continue to provide regular updates on the
company’s progress with COVID-19 testing.
About Rite Aid Corporation
Rite Aid Corporation is on the front lines of delivering
healthcare services and retail products to more than 1.6 million
Americans daily. Our pharmacists are uniquely positioned to engage
with customers and improve their health outcomes. We provide an
array of whole being health products and services for the entire
family through over 2,400 retail pharmacy locations across 18
states. Through EnvisionRxOptions, we provide pharmacy benefits and
services to approximately 4 million members nationwide. For more
information, www.riteaid.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200416005488/en/
MEDIA: Christopher Savarese (717) 975-5718
Rite Aid (NYSE:RAD)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Rite Aid (NYSE:RAD)
Historical Stock Chart
Von Apr 2023 bis Apr 2024